Agalsidase alfa: a review of its use in the management of Fabry disease
about
Clinical course of patients with Fabry disease who were switched from agalsidase-β to agalsidase-αEffect and Tolerability of Agalsidase Alfa in Patients with Fabry Disease Who Were Treatment Naïve or Formerly Treated with Agalsidase Beta or Agalsidase Alfa.Innate and Adaptive Immune Response in Fabry DiseaseComparison of intracellular and secretion-based strategies for production of human α-galactosidase A in the filamentous fungus Trichoderma reesei.
P2860
Agalsidase alfa: a review of its use in the management of Fabry disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Agalsidase alfa: a review of its use in the management of Fabry disease
@ast
Agalsidase alfa: a review of its use in the management of Fabry disease
@en
Agalsidase alfa: a review of its use in the management of Fabry disease
@nl
type
label
Agalsidase alfa: a review of its use in the management of Fabry disease
@ast
Agalsidase alfa: a review of its use in the management of Fabry disease
@en
Agalsidase alfa: a review of its use in the management of Fabry disease
@nl
prefLabel
Agalsidase alfa: a review of its use in the management of Fabry disease
@ast
Agalsidase alfa: a review of its use in the management of Fabry disease
@en
Agalsidase alfa: a review of its use in the management of Fabry disease
@nl
P2860
P1433
P1476
Agalsidase alfa: a review of its use in the management of Fabry disease
@en
P2860
P304
P356
10.2165/11209690-000000000-00000
P407
P577
2012-10-01T00:00:00Z